Fox Chase Cancer Center Endowed Chairs

Jeff is bright, a powerful communicator, and possesses impeccable integrity in the setting of strong accomplishments in science. Indeed, during his 30 years in science, he has spent an extraordinary amout of time not only immersed in cancer biology and genetics, but also working closely with surgeons, medical oncologists, and radiation oncologusts. He has a keen understanding of the spacial skills and challenges relevant to each of these disciplines in executing a robust translational research mission."
— Michael V. Seiden, MD, PhD
President and CEO,
Fox Chase Cancer Center
Launch the video: Endowed Chairs, a Living, Life-Giving Legacy

Hear from researchers why endowing a chair is so important to Fox Chase Cancer Center research, and to our patients.
See the video (7 min 25 sec)

Fox Chase Cancer Center Endowed Chair Program logoRobert C. Young MD Chair
in Cancer Research

This chair was established in 2007 through the generosity of Fox Chase Cancer Center board member Margot Keith and husband Robert Keith, as well as close friends and colleagues, to honor medical oncologist and cancer leader Robert C. Young, MD, an internationally recognized expert in lymphoma and ovarian cancer and Fox Chase’s president from 1988 to 2007.  This chair recognizes and supports an outstanding leader in the field of cancer research who represents the highest standards of excellence.

Jeff Boyd, PhD

Jeff Boyd, PhD

Senior Vice President, Molecular Medicine,
Robert C. Young, MD, Chair in Cancer Research,
Executive Director, Cancer Genome Institute,
Chief, Division of Molecular Pathology
Professor, Cancer Biology Program

Dr. Boyd has been the principle architect in the launch of the CGI, developed to explore productive collaborations with government agencies, other academic centers, and biotechnology and pharmaceutical companies. His previous position was Chief Scientific Officer.

Boyd is an international expert in translational research and has particular expertise in the genetics of breast, ovarian and endometrial cancer. He has helped define the role of tumor suppressors and oncogenes in these malignancies, most notably the p53, BRCA1 and BRCA2 tumor suppressor genes and their role in the development of breast and ovarian cancer.

Before coming to Fox Chase in 2008, Boyd was director of the Curtis and Elizabeth Anderson Cancer Institute and vice president of oncology and research at the Memorial University Medical Center in Savannah, Georgia. He also served as the professor of medicine, surgery, obstetrics and gynecology at the Mercer University School of Medicine. At Mercer University, he served as the assistant dean of research. He also holds the title of Distinguished Cancer Scholar from the state of Georgia.

Prior to his roles in Savannah, Boyd served a variety of leadership roles at the Memorial Sloan Kettering Cancer Center in New York. At MSKCC, he was director of the gynecology and breast research laboratory in the department of surgery as well as the director of diagnostic molecular genetics laboratory within the department of medicine. Before serving at MSKCC, he had faculty positions at the University of Pennsylvania, the University of North Carolina, and the National Institutes of Health (NIH).

Contact Us

Institutional Advancement
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111